Skip to main content
Clinical Trials/NCT00627549
NCT00627549UnknownNot Applicable

The Use of Avaulta Plus for Anterior Repair. A Multicenter Randomised Prospective Controlled Study

Zealand University Hospital2 sites in 1 countryStarted: March 3, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Locations
2
Primary Endpoint
Does Avaulta Plus reduce the recurrence rate defined as a POP-Q Aa <-2 cm at follow-up after 1 yr.

Study Overview

Brief Summary

Summary:

Vaginal prolapse is a well-known disease and is observed in approximately 11% of all postmenopausal women and tending to increase with age. Consequently, many surgical procedures have been developed in order to ensure sufficient support for the bladder, rectum or vaginal vault depending on the site of the defect. However, many procedures are associated with a high recurrence rate up to 40 % even within one to two years after the surgical procedure.

Due to the high recurrence rate new methods include the use of mesh, either biologically or synthetic. The latter is a permanent implant and therefore theoretically may result in a long-lasting anatomically correct position of the prolapse.

Although the recurrence rate may be lower using a mesh such surgical procedures may be associated with adverse events such as erosions of the vaginal mucosa. Others have observed shrinkage of the vaginal mucosa. However, in these studies large prolene mesh have been used. In contrast the recurrence rate is lowered up to 25%.

The above-mentioned advantage of synthetic mesh is however, mostly based on few non-randomised studies. We therefore find it of importance to evaluate whether a surgical procedure using a mesh implant is superior to conventional surgical techniques. The present study is a clinical controlled study where patients with anterior vaginal prolapse are randomised to either a mesh technique or a standard anterior procedure.

The present study includes only two more visits at the outpatient clinic after the surgical procedure. Furthermore the patients have to fulfil questionnaires regarding urinary and faecal leakage and sexual habits.

Any participation in the study is totally voluntary and the patient may at any time withdraw herself. In any case the patient will receive our standard treatment.

The study is performed in all the Scandinavian countries.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women aged > 55 yr
  • Women with anterior vaginal wall prolapse stage >2 according to POP-Q classification
  • Good understanding the language in word and writing

Exclusion Criteria

  • A history of previous major pelvic surgery with the exception of a hysterectomy for reasons other than genital prolapse
  • Patients with previous vaginal surgery because of defects in the anterior of posterior compartments
  • Previous hysterectomy because of vaginal prolapse
  • Patients with prolapse of uterus or an enterocele > stage 2
  • Patients with previous TVT performed through the obturator membrane
  • History of genital or abdominal cancer
  • Patients treated with corticosteroids
  • Not able to understand the study protocol (language problems, cognitive dysfunction etc.)

Outcomes

Primary Outcomes

Does Avaulta Plus reduce the recurrence rate defined as a POP-Q Aa <-2 cm at follow-up after 1 yr.

Time Frame: one year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials